Jiménez-García Rodrigo, Perez-Farinos Napoleón, Miguel-Díez Javier de, Hernández-Barrera Valentín, Méndez-Bailón Manuel, Jimenez-Trujillo Isabel, Miguel-Yanes José M de, López-de-Andrés Ana
Rey Juan Carlos University Health Sciences Faculty Preventive Medicine and Public Health Teaching and Research Unit Madrid Spain Preventive Medicine and Public Health Teaching and Research Unit, Health Sciences Faculty, Rey Juan Carlos University, Madrid, Spain.
Universidad de Málaga Faculty of Medicine Department of Public Health and Psychiatry Andalucía Spain Department of Public Health and Psychiatry, Faculty of Medicine, Universidad de Málaga, Andalucía, Spain.
Braz J Cardiovasc Surg. 2020 Feb 1;35(1):65-74. doi: 10.21470/1678-9741-2019-0181.
The aims of this study were to examine the incidence and in-hospital outcomes of surgical aortic valve replacement (SAVR) and to identify factors associated with in-hospital mortality (IHM) among patients according to the type of implanted valve used in SAVR.
We performed a retrospective study using the Spanish National Hospital Discharge Database, 2001-2015. We included patients who had SAVR listed as a procedure in their discharge report.
We identified 86,578 patients who underwent SAVR (52.78% mechanical and 47.22% bioprosthetic). Incidence of SAVR coding increased significantly from 11.95 cases per 100,000 inhabitants in 2001 to 17.92 in 2015 (P<0.001). Age and comorbidities increased over time (P<0.001). There was a significant increase in the frequency of concomitant coronary artery bypass grafting (CABG) and in the use of pacemaker implantation. The use of mechanical SAVR decreased and the use of bioprosthetic valves increased over time. IHM decreased over time (from 8.13% in 2001-05 to 5.39% in 2011-15). Patients who underwent mechanical SAVR had higher IHM than those who underwent bioprosthetic SAVR (7.44% vs. 6%; P<0.05). Higher IHM rates were associated with advanced age, female sex, comorbidities, concomitant CABG, and the use of mechanical SAVR (OR 1.67; 95% CI 1.57-1.77).
The number of SAVRs performed in Spain has increased since 2001. The use of mechanical SAVR has decreased and the use of bioprosthetic valves has increased over time. IHM has decreased over time for both types of valves and despite a concomitant increase in age and comorbidities of patients during the same period.
本研究旨在探讨外科主动脉瓣置换术(SAVR)的发生率及院内结局,并根据SAVR中植入瓣膜的类型确定患者院内死亡(IHM)的相关因素。
我们利用西班牙国家医院出院数据库进行了一项回顾性研究,时间跨度为2001年至2015年。我们纳入了出院报告中列出SAVR作为一项手术的患者。
我们识别出86578例接受SAVR的患者(52.78%为机械瓣膜,47.22%为生物瓣膜)。SAVR编码的发生率从2001年的每10万居民11.95例显著增加到2015年的17.92例(P<0.001)。年龄和合并症随时间增加(P<0.001)。同期冠状动脉旁路移植术(CABG)的频率及起搏器植入的使用显著增加。随着时间推移,机械SAVR的使用减少,生物瓣膜的使用增加。IHM随时间下降(从2001 - 2005年的8.13%降至2011 - 2015年的5.39%)。接受机械SAVR的患者IHM高于接受生物瓣膜SAVR的患者(7.44%对6%;P<0.05)。较高的IHM率与高龄、女性、合并症、同期CABG以及机械SAVR的使用相关(OR 1.67;95% CI 1.57 - 1.77)。
自2001年以来,西班牙进行的SAVR数量有所增加。随着时间推移,机械SAVR的使用减少,生物瓣膜的使用增加。两种类型瓣膜的IHM均随时间下降,尽管同期患者年龄和合并症有所增加。